Based on market data through Oct 30, 2026, StockInvest.us rates Kala Pharmaceuticals Inc (KALA) as a Strong Sell Candidate with a technical score of -5.41 on its -10 to +10 scale. The rating is ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Ka Vang is a writer, playwright and children’s book author. She is the vice president of equity and community impact for Meet Minneapolis, the tourism, convention and visitors’ bureau for the city of ...

You’re juggling so many roles in life-parent, partner, friend, caregiver, professional-and sometimes, in the process of caring for everyone else, it can become difficult to recognize yourself. Maybe ...

VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund 220.62k Jun 30, 2026 1.14% 36,513 Fidelity Concord Street Trust-Fidelity Extended Market Index Fund 95.98k Aug 31, 2026 0.50% 15,884 Fidelity ...

Iranian-Canadian imprisoned for terrorism challenges possible loss of citizenship as 'cruel and unusual' Hiva Alizadeh is among nine convicted terrorists notified by Citizenship and Immigration Canada ...

The agencies include the Ministry of Education, Te Aho o Te Kura Pounamu, Education New Zealand, Education Review Office (ERO), New Zealand Qualifications Authority (NZQA), The Teaching Council of ...

KALA’s recent announcements show a shift toward genetic testing, telehealth, and preventive-care services alongside its biotechnology and software efforts. The latest development is a proposed ...